Cargando…
Longitudinal analysis of complete blood count parameters in advanced‐stage lung cancer patients
BACKGROUND: Metastatic lung cancer is a debilitating disease, but with the advances in immunotherapy, therapeutic options have vastly increased. Numerous complete blood count parameters (CBC) have been described as easily accessible biomarkers that might predict response to immunotherapy. However, t...
Autores principales: | Rojko, Livia, Megyesfalvi, Zsolt, Czibula, Eszter, Reiniger, Lilla, Teglasi, Vanda, Szegedi, Zsolt, Szallasi, Zoltan, Dome, Balazs, Moldvay, Judit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605999/ https://www.ncbi.nlm.nih.gov/pubmed/32941706 http://dx.doi.org/10.1111/1759-7714.13642 |
Ejemplares similares
-
PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023) -
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
por: Gieszer, Balazs, et al.
Publicado: (2021) -
Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
por: Dora, David, et al.
Publicado: (2023) -
Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2019) -
Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain
por: Tanjore Ramanathan, Jayendrakishore, et al.
Publicado: (2020)